An introduction to the microbiome and MS

Area of Science:

• Microbiology
• Neuroimmunology
• Gastroenterology

Background:

• The human microbiota, comprising microorganisms in and on the body, is vital for health.
• Intestinal commensal species significantly affect host physiology locally and systemically.
• Multiple sclerosis (MS) is a severe autoimmune CNS disorder with no cure, and its causes remain unknown.

Purpose of the Study:

• To review the current understanding of the microbiota's role in multiple sclerosis (MS).
• To explore potential pathogenic and protective functions of the microbiota in MS progression.
• To discuss therapeutic interventions targeting the microbiota for MS symptom alleviation.

Main Methods:

• Review of existing animal studies on microbiota and MS.
• Analysis of clinical studies investigating the microbiota-MS connection.
• Synthesis of current knowledge on microbiota-host interactions in neuroimmunological diseases.

Main Results:

• Evidence suggests the microbiota plays a dual role (pathogenic and protective) in MS.
• Microbiota composition and function can influence MS pathogenesis and progression.
• Specific microbial species or metabolites may impact neuroinflammation.

Conclusions:

• The microbiota is a significant factor in MS development and progression.
• Targeting the gut microbiota offers promising therapeutic avenues for MS.
• Further research is needed to elucidate specific mechanisms and develop effective microbiota-based therapies for MS.